Drug
Ucenprubart clinical trials
Also written LY3454738.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Development codes
- LY3454738
- 4
Studies by the year they started
4 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses ucenprubart is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic DermatitisTerminatedPhase 2Eli Lilly and CompanyNCT05911841Written as LY3454738
- A Relative Bioavailability Study of LY3454738 in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT06173895Written as LY3454738
- A Study of LY3454738 in Adults With Chronic Spontaneous UrticariaTerminatedPhase 2Eli Lilly and CompanyNCT04159701Written as LY3454738
- A Study of LY3454738 in Healthy Participants and Participants With Atopic DermatitisCompletedPhase 1Eli Lilly and CompanyNCT03750643Written as LY3454738
Codes
What other systems call ucenprubart · ClinicalTrials.gg INT015828
- UNII (FDA) 99OHY1NA5OUCENPRUBARTOne source FDA
- NCI Thesaurus C203149UcenprubartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 99OHY1NA5O | UCENPRUBART | One source FDA |
| NCI Thesaurus | C203149 | Ucenprubart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.